N. Miller

Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancer.

J. Soria, V. Papadimitrakopoulou, B. Johnson, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma.

H. Goldschmidt, G. Morgan, M. Dimopoulos, 2016, Blood.

Everolimus in Combination with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Chemotherapy: A Phase I Study Using a Novel, Adaptive Bayesian Dose-Escalation Model

B. Solomon, J. Wolf, S. Dimitrijević, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer.

R. Heist, S. Dimitrijević, D. Camidge, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma and Renal Impairment: Analysis of Patients from the Phase 3b Stratus Trial (MM-010)

H. Goldschmidt, M. Dimopoulos, A. Oriol, 2014 .

Safety and ef fi cacy of pomalidomide plus low-dose dexamethasone in STRATUS ( MM-010 ) : a phase 3 b study in refractory multiple myeloma

H. Goldschmidt, G. Morgan, M. Dimopoulos, 2016 .

First-in-human study of the B7-H4 antibody-drug conjugate (ADC) AZD8205 in patients with advanced/metastatic solid tumors.

Toshio Shimizu, F. Meric-Bernstam, M. Rebelatto, 2022, Journal of Clinical Oncology.

FP14.06 Multicenter Analysis of Mechanisms of Resistance to Osimertinib (O) in EGFR Mutated NSCLC: An ATOMIC Registry Study

J. Nieva, R. Camidge, R. Doebele, 2021, Journal of Thoracic Oncology.

Everolimus in Combination with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Chemotherapy: A Phase I Study Using a Novel, Adaptive Bayesian Dose-Escalation Model

B. Solomon, J. Wolf, S. Dimitrijević, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.